PLEKHA5 and gastric cancer: Met or PLEKHA5 silencing also blocked the growth of MKN45 cells but did not affect that of other gastric cancer cell lines, including KATO-III that has FGFR2 gene amplification, and normal mesothelial cell line without Met gene amplification (Fig. 1J).